我不否认制药的单位需要一定的利润，谁也不会去做无利可图的生意。
I do not deny that drug-manufacturing companies need to earn some profits.Otherwise, no one will undertake a non-profit business.
尽管中国具有增长潜力，但主要生产仿制药的国内企业，仍占据约四分之三的市场。
In spite of China's growth potential, local companies, which mainly produce generic drugs, still account for about three quarters of the market.
像立普妥这样的拳头产品的专利过期时，来自仿制药的竞争使其价格暴跌，有时不足原价的十分之一。
When patents on blockbusters like Lipitor run out, generic competition ensures that prices collapse quickly-sometimes to a tenth of their former levels.
诺华制药的老总魏思乐博士坚决拥护近来的并购。但是也承认大公司现在必须去公司外找灵感，因为“我们无法面面俱到。”
Dr Vasella, Novartis's boss, stoutly defends recent mergers, but accepts that big firms must now look outside for inspiration because “we can't do it all ourselves.”
一家于2008年转向生物仿制制药的美国制药公司---默克公司认为进入生物仿制制药这个领域的障碍是如此之大以至于“只有几家”公司有能力成功进入。
Michael Kamarck of Merck, an American drugs firm which moved into biosimilars in 2008, thinks the barriers to entry are so great that “only a handful” of firms will be able to pull it off.
这代表着制药政策上的巨大变化。
为了加速增长，日本的制药公司一直在进行海外并购。
To speed up growth, Japanese drug companies have been buying overseas ones.
几乎所有主流制药企业都关注于肿瘤药物的研发。
Almost all major pharmaceutical companies are now focused on oncology drug development.
制药公司们越来越多地和一些较小的专业公司以及学术团体合作。
Pharmaceutical companies are increasingly partnering with smaller specialist firms and academia.
这家生物制药公司去年进行了两笔重大并购——买下了制药公司Gloucester和生物技术公司Abraxis——以推进其成为肿瘤治疗领域领导者的目标。
The biopharmaceutical company made two major acquisitions last year — the pharmaceutical company Gloucester and biotech firm Abraxis — to advance its goal of becoming an oncology leader.
卫生关注还可推动工业界的道德行为，制药公司大幅降低艾滋病药品价格就是一个例证。
Concern for health can also motivate ethical behaviour in industry, as when pharmaceutical companies dramatically cut prices for AIDS medicines.
其答案正是困扰制药公司的核心问题。
这项研究纳入了25位自愿停用免疫抑制药物而保留正常肾功能超过1年的肾移植受者。
This study included 25 kidney transplant recipients who had ceased taking their immunosuppressive drugs of their own accord and yet had retained normal kidney function for more than one year.
一些制药公司的老板现在也公开承认这个问题。
法国的制药游说团体力量强大。
辉瑞制药未来的拳头产品宣告失败，公司面临困境。
底线是，制药公司整体上在市场营销上的投资要多于在研发上的投资。
The bottom line is that pharmaceutical companies as a whole invest more in marketing than they do in research and development.
德国先进的医疗制药设备和技术，可以造福更多中国患者；
Germany's advanced medical and pharmaceutical equipments and technologies may benefit more Chinese patients.
在过去20年里，制药行业一直致力于从上千种传统中医所使用的天然药物中寻找启发。
In the past 20 years, the pharmaceuticals industry has often looked for inspiration to the thousands of natural products used in traditional Chinese medicine.
“它为制药行业松绑，这样他们就可以开始治疗这种疾病，而不仅仅是疾病的副作用。”他说。
"It unties the hands of the pharmaceutical industry so that they can begin treating the disease and not just the side effects," he said.
这为制药行业松绑，这样，他们就可以开始治疗这种疾病，而不仅仅是治疗疾病的副作用。
It unties the hands of the pharmaceutical industry so that they can begin treating the disease and not just the side effects.
这为制药行业松绑，这样，他们就可以开始治疗这种疾病，而不仅仅是治疗疾病的副作用。
It unties the hands of the pharmaceutical industry so that they can begin treating the disease and not just the side effects.
应用推荐